Methadone During Residential Rehab: How OTP Dosing Works

One of the most common questions we hear on admission calls comes from people who already take methadone, or whose doctor has recommended it: “Can I keep my dose if I come to residential treatment?” The short answer is usually yes, but not in the way most families expect. Methadone for opioid use disorder runs on its own set of federal rules, and those rules decide who can dispense it, where, and how often. Understanding the process before admission day is what prevents a missed dose.

The rule that shapes everything: only an OTP can dispense methadone for OUD

Under federal law, methadone used to treat opioid use disorder can only be dispensed through a SAMHSA-certified opioid treatment program (OTP), sometimes called a methadone clinic. A residential rehab, including a small six-bed program like Annandale Behavioral Health in the Los Angeles and Pasadena area, cannot dispense methadone for opioid use disorder on its own. Instead, the rehab coordinates with a licensed OTP that holds the prescription and supplies the doses. Federal OTP rules (42 CFR Part 8) were revised in February 2024, took effect on April 2, 2024, and became mandatory for OTPs on October 2, 2024; under the revised rules, take-home doses can be considered from the first week of treatment, but the OTP’s practitioner, not the rehab, makes that decision.

SAMHSA’s overview of methadone treatment describes this certification requirement, and its table of changes to the 42 CFR Part 8 rule lists the updated take-home, telehealth and interim-treatment provisions. California also regulates OTPs at the state level, so some details can vary by program.

In practice, this means a residential stay for someone on methadone involves two treatment teams: the residential clinical team that runs day-to-day care, and the OTP that controls the medication. Our medication-assisted treatment page explains that for patients who need methadone, we coordinate with licensed opioid treatment programs in the LA area rather than dispensing it ourselves.

Why methadone gaps happen around admission

When a dose gets missed during the move into residential care, it is almost never because anyone decided to stop the medication. It is usually one of these logistical failures:

• Unverified last dose: If no one can confirm the date, time and amount of the last methadone dose, the receiving team has to wait for the OTP to confirm before anything else happens.
• No contact with the home clinic: The OTP that currently doses the patient usually needs a signed release before it can talk to the rehab, because federal confidentiality rules protect substance use treatment records.
• Distance between clinics: Someone dosing at a clinic in another county or state may need a temporary arrangement with an OTP near the residence, and that takes time to set up.
• Weekend and holiday hours: Many clinics run reduced hours, so an admission timed for a Friday afternoon can leave little room to sort out problems before the next dose is due.
• Take-home status not transferring automatically: Take-home privileges are a clinical decision made by the treating OTP, so a new or receiving program may reassess them rather than simply carry them over.

None of these are unusual. They are the inconvenient, operational side of methadone treatment, and the fix is almost always the same: start the coordination before the admission date, not on it.

What changed in the 2024 federal rules

The revised 42 CFR Part 8 rules made methadone treatment more flexible in several ways that matter for people moving between levels of care. According to SAMHSA, adults no longer need to show one year of opioid addiction history to be admitted to an OTP. Counseling is still recommended, but patients cannot be denied services for choosing not to participate in it. Practitioners are no longer bound by rigid criteria when deciding on take-home doses, and screening to start methadone can now happen by audio-visual telehealth under certain conditions. Interim treatment, which lets an OTP at full capacity begin medication while arranging comprehensive services, was expanded from 120 to 180 days.

For families, the practical takeaway is that there is more room for individual clinical judgment than there used to be. That is good news, but it also means the answers you get depend on the specific OTP and its practitioners. Ask rather than assume.

Five questions to ask before admission day

If you or a family member takes methadone and is considering residential care, call the current OTP before the admission date and ask these questions. Write the answers down and bring them to intake.

1. What was the exact date, time and amount of the last dose? Ask the clinic to confirm it in writing if possible.
2. What release of information do you need to speak with the residential program? Sign it before admission so both teams can talk on day one.
3. Can dosing continue at a clinic near the residence during the stay? If not, ask what transfer or temporary dosing options exist.
4. What is the current take-home status, and what would change it? Ask whether any take-home doses can cover travel days.
5. Who is the contact person if something goes wrong on a weekend? Get a name and a direct number.

Then call the residential program and share those answers during the pre-admission screen. If you would like help working through this, you can reach our admissions team at (855) 778-8668.

Safety issues the residential team will watch for

Methadone is safe and effective when taken as prescribed, according to SAMHSA, but it is a long-acting medication whose active ingredients remain in the body well after its felt effects wear off. That has several practical consequences in residential care.

Combining methadone with alcohol, benzodiazepines or other sedating drugs raises the risk of dangerously slowed breathing. Many people arriving in residential treatment use more than one substance, so the intake team needs an honest picture of everything taken in recent days. Alcohol and benzodiazepine withdrawal can also cause seizures, which means stopping either one requires medical supervision rather than an attempt at home. Our medical detox page describes how withdrawal is monitored.

Dose changes during a residential stay are made by the OTP practitioner, not by the patient and not by the residential staff. Missed or doubled doses are both risky. SAMHSA advises never taking an extra dose if one is missed or if it feels like it is not working.

Finally, tolerance matters at discharge. If someone tapers off methadone or stops it during or after treatment, their tolerance to opioids drops, which raises overdose risk if they return to use. Our article on overdose risk after rehab covers why this happens and why carrying naloxone matters.

Methadone, dual diagnosis and length of treatment

Many people on methadone who come to residential treatment for a substance use disorder are also living with a co-occurring condition such as depression, anxiety, PTSD or chronic pain. In dual diagnosis care, those conditions are treated alongside the substance use disorder, and the medication plan has to account for any psychiatric medications taken with methadone. SAMHSA notes that other medications may interact with methadone and cause heart conditions, so a complete medication list at intake is important.

How long methadone treatment lasts is an individual decision. SAMHSA, citing NIDA’s research-based treatment guide, states that methadone treatment should last a minimum of 12 months, and some patients need long-term maintenance. NIDA describes opioid use disorder as a chronic, treatable condition and notes that medications for it reduce the risk of overdose death; its medications for opioid use disorder overview covers how each option works. A residential stay is typically a fraction of that timeline, which is why the OTP relationship has to be planned to continue well after discharge.

Planning the handoff out of residential care

The same coordination that matters at admission matters again at discharge. Before the last day of a residential stay, confirm with the OTP where dosing will continue, when the first post-discharge visit is, and whether take-home status will change. If the person plans to switch medications, for example from methadone to buprenorphine, that decision should be made with the prescribing practitioner well ahead of time. Our guide to buprenorphine after rehab discharge explains how to avoid a gap in that situation.

Families often ask what they can do. The most useful role is usually administrative: keep copies of release forms, note the clinic’s phone number and hours, and confirm transportation for dosing days if the person will not have take-homes. These small steps are what keep medication continuous.

When to get help right now

If someone has taken too much methadone or is showing signs of overdose, such as very slow or shallow breathing, blue lips, or being unresponsive, call 911 immediately and give naloxone if available. If you or someone you love is in emotional crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline. SAMHSA’s National Helpline is available at 1-800-662-4357 for treatment referrals.

If you are planning residential treatment and want to talk through how methadone coordination would work in your situation, call Annandale Behavioral Health at (855) 778-8668. You can also read more about our residential treatment program in Los Angeles.

This article is for educational purposes only and is not medical advice. Do not start, stop or change any medication, including methadone, without guidance from your prescribing practitioner or opioid treatment program. Treatment decisions should be made with a qualified healthcare provider who knows your full history.